248 related articles for article (PubMed ID: 12227833)
1. Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment.
Huang C; Wahlund LO; Svensson L; Winblad B; Julin P
BMC Neurol; 2002 Sep; 2():9. PubMed ID: 12227833
[TBL] [Abstract][Full Text] [Related]
2. Voxel- and VOI-based analysis of SPECT CBF in relation to clinical and psychological heterogeneity of mild cognitive impairment.
Huang C; Wahlund LO; Almkvist O; Elehu D; Svensson L; Jonsson T; Winblad B; Julin P
Neuroimage; 2003 Jul; 19(3):1137-44. PubMed ID: 12880839
[TBL] [Abstract][Full Text] [Related]
3. Regional cerebral blood flow differences in patients with mild cognitive impairment between those who did and did not develop Alzheimer's disease.
Park KW; Yoon HJ; Kang DY; Kim BC; Kim S; Kim JW
Psychiatry Res; 2012; 203(2-3):201-6. PubMed ID: 22980226
[TBL] [Abstract][Full Text] [Related]
4. The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT.
Hirao K; Ohnishi T; Hirata Y; Yamashita F; Mori T; Moriguchi Y; Matsuda H; Nemoto K; Imabayashi E; Yamada M; Iwamoto T; Arima K; Asada T
Neuroimage; 2005 Dec; 28(4):1014-21. PubMed ID: 16129627
[TBL] [Abstract][Full Text] [Related]
5. Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease.
Encinas M; De Juan R; Marcos A; Gil P; Barabash A; Fernández C; De Ugarte C; Cabranes JA
Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1473-80. PubMed ID: 14579086
[TBL] [Abstract][Full Text] [Related]
6. Cerebral Blood Flow Predicts Conversion of Mild Cognitive Impairment into Alzheimer's Disease and Cognitive Decline: An Arterial Spin Labeling Follow-up Study.
Duan W; Zhou GD; Balachandrasekaran A; Bhumkar AB; Boraste PB; Becker JT; Kuller LH; Lopez OL; Gach HM; Dai W
J Alzheimers Dis; 2021; 82(1):293-305. PubMed ID: 34024834
[TBL] [Abstract][Full Text] [Related]
7. Effect of linearization correction on statistical parametric mapping (SPM): a 99mTc-HMPAO brain perfusion SPECT study in mild Alzheimer's disease.
Ansar MA; Osaki Y; Kazui H; Oku N; Takasawa M; Kimura Y; Begum NN; Ikejiri Y; Takeda M; Hatazawa J
Ann Nucl Med; 2006 Oct; 20(8):511-7. PubMed ID: 17134017
[TBL] [Abstract][Full Text] [Related]
8. (99m)Tc hexamethyl-propylene-aminoxime single-photon emission computed tomography prediction of conversion from mild cognitive impairment to Alzheimer disease.
Devanand DP; Van Heertum RL; Kegeles LS; Liu X; Jin ZH; Pradhaban G; Rusinek H; Pratap M; Pelton GH; Prohovnik I; Stern Y; Mann JJ; Parsey R
Am J Geriatr Psychiatry; 2010 Nov; 18(11):959-72. PubMed ID: 20808143
[TBL] [Abstract][Full Text] [Related]
9. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
[TBL] [Abstract][Full Text] [Related]
10. Imaging markers of mild cognitive impairment: multivariate analysis of CBF SPECT.
Huang C; Eidelberg D; Habeck C; Moeller J; Svensson L; Tarabula T; Julin P
Neurobiol Aging; 2007 Jul; 28(7):1062-9. PubMed ID: 16824650
[TBL] [Abstract][Full Text] [Related]
11. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
Johnson NA; Jahng GH; Weiner MW; Miller BL; Chui HC; Jagust WJ; Gorno-Tempini ML; Schuff N
Radiology; 2005 Mar; 234(3):851-9. PubMed ID: 15734937
[TBL] [Abstract][Full Text] [Related]
12. Cholinergic enhancement increases regional cerebral blood flow to the posterior cingulate cortex in mild Alzheimer's disease.
Iizuka T; Kameyama M
Geriatr Gerontol Int; 2017 Jun; 17(6):951-958. PubMed ID: 27215917
[TBL] [Abstract][Full Text] [Related]
13. [Prediction of progression in patients with mild cognitive impairment using IMP-SPECT].
Okamura N; Shinkawa M; Arai H; Matsui T; Nakajo K; Maruyama M; Hu XS; Sasaki H
Nihon Ronen Igakkai Zasshi; 2000 Dec; 37(12):974-8. PubMed ID: 11201187
[TBL] [Abstract][Full Text] [Related]
14. Cerebral perfusion (HMPAO-SPECT) in patients with depression with cognitive impairment versus those with mild cognitive impairment and dementia of Alzheimer's type: a semiquantitative and automated evaluation.
Staffen W; Bergmann J; Schönauer U; Zauner H; Kronbichler M; Golaszewski S; Ladurner G
Eur J Nucl Med Mol Imaging; 2009 May; 36(5):801-10. PubMed ID: 19137294
[TBL] [Abstract][Full Text] [Related]
15. Working memory load-related electroencephalographic parameters can differentiate progressive from stable mild cognitive impairment.
Missonnier P; Deiber MP; Gold G; Herrmann FR; Millet P; Michon A; Fazio-Costa L; Ibañez V; Giannakopoulos P
Neuroscience; 2007 Dec; 150(2):346-56. PubMed ID: 17996378
[TBL] [Abstract][Full Text] [Related]
16. Posterior cingulate hypoperfusion in Alzheimer's disease, senile dementia of Alzheimer type, and other dementias evaluated by three-dimensional stereotactic surface projections using Tc-99m HMPAO SPECT.
Kaneko K; Kuwabara Y; Sasaki M; Ogomori K; Ichimiya A; Koga H; Nakagawa M; Hayashi K; Honda H
Clin Nucl Med; 2004 Jun; 29(6):362-6. PubMed ID: 15166883
[TBL] [Abstract][Full Text] [Related]
17. Functional interactions between entorhinal cortex and posterior cingulate cortex at the very early stage of Alzheimer's disease using brain perfusion single-photon emission computed tomography.
Hirao K; Ohnishi T; Matsuda H; Nemoto K; Hirata Y; Yamashita F; Asada T; Iwamoto T
Nucl Med Commun; 2006 Feb; 27(2):151-6. PubMed ID: 16404228
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a [99mTc]-d,l-HMPAO SPECT study.
Waldemar G; Bruhn P; Kristensen M; Johnsen A; Paulson OB; Lassen NA
J Neurol Neurosurg Psychiatry; 1994 Mar; 57(3):285-95. PubMed ID: 8158175
[TBL] [Abstract][Full Text] [Related]
19. Regional cerebral blood flow measured by 99mTc-HMPAO SPECT differs in subgroups of Alzheimer's disease.
Soininen H; Helkala EL; Kuikka J; Hartikainen P; Lehtovirta M; Riekkinen PJ
J Neural Transm Park Dis Dement Sect; 1995; 9(2-3):95-109. PubMed ID: 8527009
[TBL] [Abstract][Full Text] [Related]
20. Preclinical evidence of Alzheimer changes in progressive mild cognitive impairment: a qualitative and quantitative SPECT study.
Ishiwata A; Sakayori O; Minoshima S; Mizumura S; Kitamura S; Katayama Y
Acta Neurol Scand; 2006 Aug; 114(2):91-6. PubMed ID: 16867030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
